| Odyssey Gold Ltd (ODY) ORDINARY FULLY PAID |
Materials |
$34 |
September 2025 Quarterly Report
|
29 Oct 2025 9:03AM |
$0.031 |
$0.024 |
fallen by
22.58%
|
|
ODY - Price-sensitive ASX Announcement
Full Release
Key Points
- Odyssey Gold Limited continues to focus on the Tuckanarra Gold Project, located in the Murchison Goldfields of Western Australia.
- A Mining Technical Study was completed to assess mining options at Tuckanarra and process at the nearby Burnakura Processing Plant.
- The study results were positive, leading to a Scoping Study to be undertaken next.
- Preliminary metallurgical testwork showed high recoveries, with LeachWELLTM recoveries of 95-97% across samples.
- A 5,232-metre reverse circulation (RC) infill drilling program was completed at Tuckanarra to upgrade Inferred Mineral Resources to Indicated Mineral Resources.
- Significant drilling intersections included 20m @ 7.1g/t Au from 47m, among others.
- A new 5,000-metre RC drilling program commenced, focused on the Highway deposit and the new Cable hanging wall structure.
- The company raised $4 million through a share placement to fund ongoing exploration and development.
- Total Mineral Resource Estimate for Tuckanarra stands at 5.14 million tonnes at 2.5 g/t Au for 407,000 ounces of gold.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$51 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2025 9:03AM |
$0.125 |
$0.100 |
fallen by
20%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Narmafotinib clinical trials show a 33% objective response rate in metastatic pancreatic cancer.
- Ethics approval received for a trial combining narmafotinib with FOLFIRINOX in Australia.
- Successful capital raise of $27.5 million, funding operations into 2027.
- Cash balance of $29.2 million as of September 2025, enhanced by a $3.8 million tax incentive refund.
- Total payments of $172,500 to related parties for director fees and salaries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$24 |
Appendix 4C and Market Update
|
29 Oct 2025 9:02AM |
$0.096 |
$0.069 |
fallen by
28.13%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences completed a successful capital raise of $3.75 million, oversubscribed by institutional and sophisticated investors.
- ColoSTAT® manufacturing validation was completed by QUANSYS, and the NATA accreditation process is underway.
- The company achieved strategic partnerships for geneTypeTM with key organizations, including a major Australian pathology provider and the Know Your Lemons Foundation.
- ColoSTAT® showed a sensitivity of 91% and a high negative predictive value of 98% for detecting colorectal cancer in high-risk individuals.
- Strong operating performance in Q1 FY26, with progress towards FY26 objectives and commercial readiness of ColoSTAT®.
- Rhythm’s product portfolio focuses on disease screening through minimally-invasive detection methods and personalized health management.
- Significant progress made in geneTypeTM revenue growth, over 100% quarter-on-quarter, supported by strategic distribution partnerships.
- Upcoming RDTI refund expected to further support operations and financial stability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$85 |
Update - Notification of buy-back - CAM
|
29 Oct 2025 9:01AM |
$0.680 |
$0.610 |
fallen by
10.29%
|
|
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
ADS - Price-sensitive ASX Announcement
Full Release
Key Points
- Net operating cash outflow for the quarter was $0.57M.
- Total capital raised during the quarter was $989,000.
- Cash receipts from customers were $3.42M, a 21% increase from the previous quarter.
- Annualized salary cost savings of $5.24M achieved.
- Cash at the end of the quarter was $1.89M.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$31 |
Update - Notification of buy-back - EPY
|
29 Oct 2025 9:00AM |
$0.210 |
$0.125 |
fallen by
40.48%
|
|
| Tyranna Resources Limited (TYX) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.005 |
$0.002 |
fallen by
60%
|
|
TYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Application for extension of Namibe Project term until October 2026.
- Focus on caesium mineral pollucite at Muvero and Loop Prospects.
- Acquisition of 75% shareholding in AGFC E Filos, LDA.
- Completion of initial steps to acquire 70% interest in Maongo Copper-Gold Project.
- Cash reserves of $2.55 million and no debt at quarter-end.
- Net cash outflow for operations was $0.667 million.
- Payments to related parties totaled $175,000.
- Significant exploration and evaluation expenses reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Oct 2025 9:00AM |
$0.031 |
$0.014 |
fallen by
54.84%
|
|
LMG - Price-sensitive ASX Announcement
Full Release
Key Points
- EPA Victoria reissued the Pilot Project Licence for LMG.
- Successful production of magnesium oxide at the Demonstration Plant.
- Completion of $6M placement and $4M rights issue for supporting operations.
- U.S. Export Import Bank issued a Letter of Interest for AUD $200M financing.
- Ongoing development of a 10,000 tpa Commercial Plant in Victoria.
- Legal confirmation for importing feedstock to Malaysia for the 'Mega' Plant.
- Proceeds from surplus land sale and R&D rebate expected to aid financial stability.
- LMG’s projects focus on recycling, reducing landfill, and low CO2 emissions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$786 |
Government confirms Kangankunde unaffected by Export Order
|
29 Oct 2025 9:00AM |
$0.305 |
$0.425 |
risen by
39.34%
|
|
LIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Lindian Resources Limited receives confirmation from Malawi Government that Kangankunde mine is unaffected by export order.
- Kangankunde Rare Earths Project will not export raw minerals but a monazite concentrate.
- The project has strong infrastructure, community, and government support.
- Lindian has a strategic partnership with Iluka Resources Ltd and funding for Kangankunde.
- The Executive Order No. 2 of 2025 mandates local beneficiation of minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,499 |
Notification of cessation of securities - MFG
|
29 Oct 2025 8:59AM |
$10.080 |
$8.540 |
fallen by
15.28%
|
|
| Fitzroy River Corporation Ltd (FZR) ORDINARY FULLY PAID |
Energy |
$35 |
Quarterly Activities & Cashflow Report
|
29 Oct 2025 8:59AM |
$0.170 |
$0.325 |
risen by
91.18%
|
|
FZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Royalty income of $171,609 received during the quarter.
- Total royalty receipts for the year to 30 September 2025 were $619,145.
- Buru Royalty involves a 2-year extension for a Production Licence over the Rafael Gas and Condensate Field.
- Bowden’s Silver Project development information submitted to the New South Wales Department.
- Snowy River Gold Project funded through a $150 million equity raise.
- Company faced risks from oil and gas price volatility due to geopolitical tensions.
- Corporate and administrative costs amounted to $142,342 for the quarter.
- Report approved for release by Fitzroy River Corporation Ltd's Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,499 |
Update - Notification of buy-back - MFG
|
29 Oct 2025 8:59AM |
$10.080 |
$8.540 |
fallen by
15.28%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$342 |
Update - Notification of buy-back - RG8
|
29 Oct 2025 8:58AM |
$2.410 |
$2.440 |
risen by
1.24%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$19 |
Quarterly Business Update and Appendix 4C - September 2025
|
29 Oct 2025 8:58AM |
$0.343 |
$0.135 |
fallen by
60.58%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ received a worldwide license for an exosomal ovarian cancer biomarker.
- Published data on the efficacy of CAR-T-exosomes in cancer treatment.
- Completed a $9.5 million placement to fund developments.
- Reported $4.8 million in cash with a net operating cash outflow of $1.65 million.
- Advancing ovarian cancer test and CAR-NK-exosome therapy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,562 |
Update - Notification of buy-back - WOR
|
29 Oct 2025 8:58AM |
$14.300 |
$9.385 |
fallen by
34.37%
|
|
| Lightning Minerals Ltd (L1M) ORDINARY FULLY PAID |
Materials |
$4 |
Completion of Drilling at Mt Turner Gold Project
|
29 Oct 2025 8:58AM |
$0.049 |
$0.011 |
fallen by
77.55%
|
|
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$181 |
HK Distributor Signed as Remplir Expands in the Asian Market
|
29 Oct 2025 8:57AM |
$1.120 |
$0.665 |
fallen by
40.63%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell Limited appoints MontsMed as exclusive distributor for Remplir in Hong Kong.
- First surgical cases and sales in Hong Kong expected soon.
- Asia is a strategic pillar valued at over US$3.5 billion in total addressable market.
- Hong Kong approval provides access to Greater Bay Area with a population of around 100 million.
- Momentum building in Singapore with Device Technologies Asia and pending sales in Thailand by 2026.
- Australian-based Commercial Director appointed to oversee commercialization and distributor management in Asia.
- Orthocell is executing a global commercialization strategy with a strong balance sheet of over $50 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
29 Oct 2025 8:56AM |
$1.920 |
$1.950 |
risen by
1.56%
|
|
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$48 |
Notification of Cancellation of Shares - Form 484
|
29 Oct 2025 8:56AM |
$0.745 |
$0.575 |
fallen by
22.82%
|
|
| Ausbil Active Dividend Income Fund - Active ETF (DIVI) |
Financials |
$614 |
Estimated Distribution - October 2025
|
29 Oct 2025 8:56AM |
$11.320 |
$11.310 |
fallen by
0.09%
|
|
| Kalina Power Limited (KPO) ORDINARY FULLY PAID |
Utilities |
$51 |
Notice of Annual General Meeting / Proxy Form
|
29 Oct 2025 8:55AM |
$0.019 |
$0.017 |
fallen by
10.53%
|
|
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$48 |
Notification of cessation of securities - SB2
|
29 Oct 2025 8:54AM |
$0.745 |
$0.575 |
fallen by
22.82%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$236 |
Tunkillia Upgrade Drilling - Update
|
29 Oct 2025 8:54AM |
$1.105 |
$0.870 |
fallen by
21.27%
|
|
| Right Resources Limited (RRE) ORDINARY FULLY PAID |
Materials |
$10 |
NSW Pilot Gold Project Drives Oversubscribed $10M IPO
|
29 Oct 2025 8:52AM |
$0.030 |
$0.079 |
risen by
163.33%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$85 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Oct 2025 8:51AM |
$0.500 |
$0.465 |
fallen by
7%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- ROXUS® development milestones achieved, progressing towards US market launch in H1 2026.
- Scientific Advisory Board strengthened with leading US erectile dysfunction specialists.
- SPONTAN® validated to deliver up to 5 times faster onset than oral tablets.
- 100% patient satisfaction reported in post-prostatectomy erectile dysfunction treatment.
- Strategic equity stake in LevOmega Pty Ltd secured, expanding into the omega-3 market.
- Strong cash position with $29.7 million available, supporting operational momentum.
- Appendix 4C outlines cash flows with investments primarily in R&D and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
